34justice

Tag: Martin Shkreli

• 2016 Election Business Health Care and Medicine US Political System

  Big Pharma: Don’t Hate the Player, Hate the Game

  Martin Shkreli is a man I admire in an odd sort of way. The recent controversy involving Mr. Shkreli and his price hike of the toxoplasmosis drug, Daraprim, seems to have caused misguided furor towards the 32-year-old CEO of Turing Pharmaceuticals. He may epitomize a major problem with the pharmaceutical…

  September 30, 2015